On Thursday, August 6, Laboratorios Richmond sponsored together with Fundación Helios Salud and Fundación Huésped a Round Table in La Rural about the topic "What's new with the new drugs against the HIV virus?".
This lecture-discussion was led by Dr. Pedro Cahn (Fundación Huésped), Dr. Isabel Cassetti (Fundación Helios Salud) and Dr. Daniel Pryluka (Associate Director of Career Specialist in Infectious Diseases UBA).
At the conference were discussed which are the new drugs and the recommended regimes in first-line treatment (new patients) and rescue therapy (patients with treatment failure), according to the main international guides.
This occurred within the 7th International Symposium on HIV "Updating" organized by Fundación Helios Salud in Buenos Aires, in which Laboratorios Richmond participated with a booth, sponsoring the launch of VIRONTAR N, the first Fixed Dose Combination Darunavir 800 mg and ritonavir 100 mg in Argentina.